News & Events - Instylla

Press Releases

July 26, 2022

Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models

March 15, 2022

Instylla First-In-Human Clinical Trial Published Results Demonstrate Technical Success and Persistent Embolization Across All Patients

March 30, 2021

Instylla Announces Enrollment of Initial Patients in the Embrace^™ Hydrogel Embolic System Global Randomized Multi-Center Clinical Trial

October 14, 2020

Instylla Announces Completion of Series B Financing

In the News

March 15, 2022

A Phase I First-in-Human Study of Embrace a Polyethylene Glycol Based Liquid Embolic in the Embolization of Malignant and Benign Hypervascular Tumors

March 9, 2022

Evaluation of a Hydrogel Liquid Embolic Agent in a Porcine Mesenteric Hemorrhage Model

July 22, 2021

Instylla: An Easy, Predictable, and Simpler Way to Embolize Tumors

May 20, 2021

A Water-Based Liquid Embolic: Evaluation of its Safety and Efficacy in a Rabbit Kidney Model

March 31, 2021

Evaluation of a novel hydrogel intravascular embolization agent in a swine model of fatal uncontrolled solid organ hemorrhage and coagulopathy

Events

GEST_2022_Logo_Color-01

GEST 2022

Global Embolization Oncology Symposium Technologies (GEST) 16th Annual Meeting

SIR 2022

SIR 2022

Society of Interventional Radiology (SIR) 47th Annual Scientific Meeting